Skip to main content

. 1993 Sep 25;307(6907):771–772. doi: 10.1136/bmj.307.6907.771

Problems in assessing contents of metered dose inhalers.

D J Williams ¹, A C Williams ¹, D G Kruchek ¹

PMCID: PMC1696424 PMID: 8219948

771

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Pearce N., Crane J., Burgess C., Jackson R., Beasley R. Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy. 1991 Jul;21(4):401–410. doi: 10.1111/j.1365-2222.1991.tb01679.x. [DOI] [PubMed] [Google Scholar]
Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
Vathenen A. S., Knox A. J., Higgins B. G., Britton J. R., Tattersfield A. E. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet. 1988 Mar 12;1(8585):554–558. doi: 10.1016/s0140-6736(88)91352-9. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES